Life Sciences

Like many industries, the biopharmaceutical sector in Massachusetts is working to increase diversity, equity, and inclusion among its workforce, leadership, and supplier channels.

Commonwealth Fusion Systems, which is building a $300-million, 47-acre headquarters in Devens, announced on Wednesday it has closed on more than $1.8 billion in Series B funding to commercialize fusion energy.

Biostage, Inc., a biotech company in Holliston working to bring throat implants to the market, hired its founder and former CEO David Green back to lead the company after roughly six years of absence, according to a Tuesday press release.

Framingham biotech company SCIEX announced a supply relationship with RedShiftBio, a Burlington firm specializing in analytical instrumentation for therapeutic drugs.

The 9/90 Corporate Center, a four-building office and lab campus in Framingham, sold for $93 million in a multi-property deal closed on Wednesday, Newmark Group, Inc., who brokered the deal, announced.

The number of women sitting on Massachusetts biopharmaceutical company boards has increased 164% since 2017, according to a new report from a voluntary survey conducted by industry group MassBio released Wednesday.

Construction of a 120,600-square-foot biotech facility has been approved by the City of Marlborough, according to Lincoln Property Co., a real estate developer based in Texas with offices in Boston.

Marlborough medical device manufacturer Hologic, Inc., earned profits of $329 million in the fourth quarter, a 34% decrease from the fourth quarter 2020's profits of $494 million, according to the company's earnings report.

The former Allegro MicroSystems building at 115 Northeast Cutoff in Worcester has been rebranded as I-290Connector, as Worcester-based developer Chacharone Properties renovates the 130,000-square-foot former Allegro building into flex/lab space.

Quinsigamond Community College in Worcester is partnering with Worcester incubator Massachusetts Biomedical Initiatives and biopharmaceutical company AbbVie, which has an outpost in the city, to pilot an entry-level Biomanufacturing On-Ramp Workshop intended to help encourage participants to entry the biomanufacturing industry pipeline.